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Dear Editor,
Congenital maxillomandibular syngnathia of the jaws,
is a rare condition that has a wide variety of presenta-
tions (1). As the fusion may be unilateral or bilateral, in
some cases, bony or soft tissue adhesions between the
mandible and maxilla may be accompanied by the cleft lip
and palate, aglossi and popliteal pterygium.
Restricted mouth opening can lead to problems with
feeding, swallowing and respiratory functions therefore
affecting the growth of the infant. Early diagnosis and
management is important to reduce these problems and
avoid the risk of aspiration. Hereby, we present a case with
congenital maxillomandibular synechiae, with buccal mu-
cosa and the gingival adhesions who underwent surgical
division and successful tracheostomy procedure under ke-
tamine and dexmedetomidine sedation.
A 1-day-old female newborn (weight 3180 g) suffering
from lack of mouth opening since birth was brought to
our plastic surgery clinic for evaluation. The patient was
referred to the Plastic and Reconstructive surgery depart-
ment on account of inability to open the mouth and diffi-
culty in feeding secondary to her anatomical defect. The
mother had an uncomplicated pregnancy and received
proper prenatal care. In family’s medical history, it was
learned that their first child had also same congenital
anomaly and died 3 months after birth due to respiratory
complication.
In examination, it was seen that the lips could be sepa-
rated but the maxillary and the mandibular gingivae were
fused completely at the occlusal level anteriorly and the
baby’s mouth opening was approximately 1 mm.
She had micrognathia and in addition, bony and mus-
cular involvement in the synechiae was noted in radiologi-
cal evaluation. Cranial and abdominal ultrasonography in
newborn was normal and patent ductus arteriosus was de-
tected in echocardiographic evaluation. Laboratory blood
exam values were within normal limits.
It was decided to divide synechiae surgically. At the
same time surgical preperations were made for the pos-
sibility of tracheostomy. The patient was monitored with
noninvasive blood pressure, five-channel EKG and pulse
oxymeter in the operating room. After pretreatment with
atropine 0.02 mg.kg-1 i.v. ketamine 1 mg.kg-1 was adminis-
tered. Dexmedetomidine (Precedex, Abbott) was started as
infusion at 0.7 - 1µg.kg-1.h-1. After sedation with dexmedeto-
midine and ketamine the patient had spontaeous breath-
ing and was oxygenated (4 L.min-1) via a flexible nasopha-
ryngeal tube.
Following local anesthetic injection (1% lidocaine
with 1:100,000 epinephrine) into the adhesive areas, the
synechiae were divided using surgical scissors. The mouth
opening was immediately improved to approximately
7 mm, however, there was still a restriction in mouth
movement. In addition, there was also a cleft hard palate.
Therefore, it was decided to perform gastrostomy with tra-
cheostomy in order to protect the patient from aspiration
of regurgitated gastric contents and feeding material.
Tracheostomy was performed with dexmedetomidine
sedation while spontaneous breathing was maintained. Ef-
fective sedation was provided during this procedure and
well tolarated by the patient. A minimal change in vital
signs during the surgery and serious adverse events (such
as bronchospasm, desaturation, bradycardia) were not ob-
served. After succesfull tracheostomy, the dexmedetomi-
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dine infusion was discontinued and anesthesia was main-
tained with sevoflurane 1.2% - 1.5% and 50%:50% oxygen and
air. Operation lasted 45 minutes. At the end of the surgery,
patient was transferred to the pediatric intensive care unit
without any respiratory adverse effect.
Congenital alveolar synechiae is an uncommon defect.
It can be found in any part of oral cavity and generally
includes fibrous and supportive tissue such as muscle or
bone and membranes or bands of epithelium (2). It can be
associated with microglossia, micrognathia, cleft palate or
syndromes like Vander de Woude, and Pierre-Robin (1, 2).
Fibrous alveolar synechiae without bone or muscle ab-
normalities have good outcomes when properly excised.
But, this defect is becoming more complex for surgical in-
tervention in cases involving bone tissue as in our patient.
In order to treat the patient effectively, it is very important
to secure the airways and ensure adequate nutrition until
enough mouth opening is provided. Therefore, we had de-
cided for gastrostomy and tracheostomy in our patient.
Dexmedetomidine is a more selective α2-adrenergic
receptor agonist than clonidine. It has been reported to
provide reliable rapid and stable sedation, analgesia, and
hemodynamic modulation, without clinically significant
respiratory depression (3). Hypotension and bradycardia
are the most prominent and often dose-limiting side ef-
fects of dexmedetomidine.
Ketamine is another popular anesthetic which has
both sedative and analgesic properties. But ketamine, can
also induce adverse cardiostimulatory effects and postop-
erative delirium when used as a sole sedative agent (4).
There are various publications in the literature regard-
ing the use of ketamine and dexmedetomidine for seda-
tion in different pediatric surgical procedures (3). Bozdo-
gan et al. (5) showed that bolus doses of ketamine 1 mg.kg-1
and dexmedetomidine 1 µg.kg-1 followed by a continuous
infusion of dexmedetomidine 0.7 - 1µg.kg-1.h-1 provided ex-
cellent anesthetic conditions to perform caudal anesthesia
and inguinal hernia repair in three high-risk infants.
Levanen and colleagues (4) also emphasized that the
combined use of ketamine and dexmedetomidine will
neutralize the expected side effects of each other.
The sympathomimetic properties of ketamine helped
to maintain hemodynamics in our patient and prevent
bradycardia and hypotension. Also, in our cases, there
were no episodes of airway obstruction reported, the res-
piratory rate remained stable.
Especially in cases where mask ventilation and pos-
sibility of intubation is difficult, maintenance of sponta-
neous breathing and airway is important. The characteris-
tic of dexmedetomidine and ketamine to provide sedation
with minimal respiratory depression makes them suitable
anesthetic agents for this procedure.
In sumary, the combination of dexmedetomidine, ke-
tamine and local anesthesia provided an adequate depth
of anesthesia and analgesia for surgical division and tra-
cheostomy operation in our patient. We believe that the
combined use of dexmedetomidine and ketamine should
be reminded by different case presentations and clinical
trials in order to achieve the best clinical scenario for pos-
sible benefits and safety profile.
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